Dr. Steven Treon, from the Dana-Farber Cancer Institute, is coming to Sarasota! Dr. Treon will be sharing an update on the current advances in clinical and laboratory research from the Bing Center for Waldenstrom’s Macroglobulinemia. Dr. Luis Chu, of Florida Cancer Specialists & Research Institute, Sarasota, will also be available for questions.

Professor Treon speaking to delegates of the 79th Annual Meeting of the Japanese Society of Hematology. One hundred and fifty delegates to the 79th Annual Meeting of the Japanese Society of Hematology attended a workshop on Waldenstrom’s Macroglobulinemia, which featured Dr. Steve Treon, Professor of Medicine at Harvard Medical School and Director of the Bing Center for WM at the Dana Farber Cancer Institute.

Steve Treon with hematologists in training at the Masterclass on WM at the Haematology Association of Ireland, Belfast. Fifty hematologists in training attended the Masterclass on Waldenstrom’s Macroglobulinemia held as part of the Annual Meeting of the Hematology Association of Ireland (HAI) in Belfast. Dr. Steve Treon of the Bing Center for WM at the Dana Farber Cancer Institute gave a State of the Art Keynote lecture on Friday, October 13, 2017 entitled “Genomic and Treatment Advances in Waldenstrom’s Macroglobulinemia”.

On a beautiful crisp fall day, October 14th, we were blessed to have Dr. Jorge Castillo, from the Bing Center of Dana Farber, come to speak with us in Denver about WM. He was fantastic! We had 62 patients and caregivers present to hear him, share a breakfast snack, and integrate the newly diagnosed people into our group! We are getting about 8-10 new patients each year and all of them love the camaraderie, the knowledge, the sharing of ideas and hope that our group provides. One of the new patients drove all the way from Santa Fe, NM to join us!

For those within the Los Angeles/Orange County areas, Dr Steven Treon will be lecturing on Updates in the Diagnosis and Treatment for Waldenstrom’s macroglobulinemia (WM) on Sunday, November 19th, 2017. If you are in the area and interested in attending, please RSVP to Marla Chao of the IWMF L.A./ Orange County support group. Click here for more details on this meeting.

For those within the San Diego, California area, Dr Steven Treon will be lecturing on Updates in the Diagnosis and Treatment for Waldenstrom’s macroglobulinemia (WM) on Saturday, November 18th, 2017. If you are in the area and interested in attending, please RSVP to Kathy Battle of the IWMF San Diego support group. Click here for more details on this meeting.

Christopher Patterson

Phone: 617-632-6285Email:This email address is being protected from spambots. You need JavaScript enabled to view it.

Chris Patterson is the Administrative Director of the Bing Center for Waldenstrom’s Macroglobulinemia. After completing his undergraduate studies at Kings College, and the University of Heidelberg in Germany, Chris studied immunology and biochemistry at the Harvard University Extension School, Cambridge MA. In 2005, Chris joined the Bing Center as a Clinical Research Coordinator and was responsible for clinical trials examining the role of sildenafil, imatinib mesylate, and bortezomib in the treatment of Waldenstrom’s Macroglobulinemia. In 2007, he undertook the role of Administrative Director for the Bing Center, and led the expansion of the Bing Center Basic Science and Clinical Trial Efforts. In 2008, Chris served as the Secretariat of the highly successful 5th International Workshop on Waldenstrom’s Macroglobulinemia which took place in Stockholm, Sweden and attracted senior and young investigators from around the world for a 4 day scientific workshop on WM. For his efforts, Chris was honored at the closing ceremonies, which took part in the Nobel Hall. In 2009, Chris organized the 3rd International Summit on WM, which brought over 600 patients and physicians to Boston for a 3-day Summit on WM. In addition to his administrative roles, Chris has been a strong advocate for WM patient education, and is also the coordinator for the New England WM Support Group. He has organized numerous regional WM support group meetings throughout North America and Europe, including the 2009 Toronto Summit on WM. Among his research interests, Chris undertook studies addressing cholesterol and iron deficiency in WM, as well as characterizing the familial basis of WM. He has served as a co-investigator for the Familial WM Program, which is funded by the International Waldenstrom’s Macroglobulinemia Foundation and has attracted hundreds of patients and their family members for comprehensive studies addressing the genetic basis of Familial WM. His studies have also identified Hepcidin as a mediator of iron deficiency in WM. He has been a co-author for numerous papers and abstracts published in WM, including those published in Blood, Clinical Cancer Research, Clinical Lymphoma Myeloma and the Journal of Clinical Oncology, and has presented at national meetings including the American Society of Hematology and the American Society for Clinical Oncology. He also served as a co-editor for a Special Edition on WM which was published in 2009 in Clinical Lymphoma Myeloma.